Literature DB >> 20420897

Growth inhibitory and apoptosis inducing by effects of total flavonoids from Lysimachia clethroides Duby in human chronic myeloid leukemia K562 cells.

Yan-li Liu1, Li-hua Tang, Zhong-qin Liang, Ben-gang You, Shi-lin Yang.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Lysimachia clethroides Duby is a traditional Chinese medicinal herb has been used in China to treat edema, jaundice diseases, hepatitis, tumor and inflammations, but the anti-tumor mechanisms are unclear. AIM OF THE STUDY: The present study was undertaken to investigate if total flavonoids from Lysimachia clethroides Duby (ZE4) possesses anti-cancer effects through apoptotic pathways in human chronic myeloid leukemia K562 cells.
MATERIALS AND METHODS: K562 cells were treated with different concentrations of ZE4 at different time intervals. Cell viability was measured by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. Cell apoptosis was assessed by flow cytometry, Hoechst 33258 staining and COMET assay. Western blot analysis was used to detect Bcl-2, Trail and DR5 expressions.
RESULTS: 15 flavonoids were isolated and identified from ZE4. ZE4 could inhibit the growth of K562 cells significantly by induction of apoptosis. Marked morphological changes of apoptosis, DNA fragmentation and single DNA strand breakages were observed clearly after treatment of ZE4. Bcl-2 expression was down-regulated remarkably while Fas, Trail and DR5 up-regulated when apoptosis occurred.
CONCLUSIONS: This result suggests that total flavonoids of Lysimachia clethroides Duby exert potential anti-cancer activity through growth inhibition and apoptosis in K562 cells. (c) 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20420897     DOI: 10.1016/j.jep.2010.04.008

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  8 in total

1.  Investigation of the extracts from Bidens pilosa Linn. var. radiata Sch. Bip. for antioxidant activities and cytotoxicity against human tumor cells.

Authors:  Jianguo Wu; Zhongxian Wan; Jun Yi; Yanbin Wu; Wei Peng; Jinzhong Wu
Journal:  J Nat Med       Date:  2012-03-01       Impact factor: 2.343

2.  Induction of apoptosis and G2 /M cell cycle arrest by Scrophularia striata in a human leukaemia cell line.

Authors:  A Azadmehr; R Hajiaghaee; M Mazandarani
Journal:  Cell Prolif       Date:  2013-12       Impact factor: 6.831

3.  Anti-carcinogenic effects of the phenolic-rich extract from abnormal Savda Munziq in association with its cytotoxicity, apoptosis-inducing properties and telomerase activity in human cervical cancer cells (SiHa).

Authors:  Guzalnur Abliz; Fatima Mijit; Li Hua; Guzalnur Abdixkur; Tangnur Ablimit; Nurmuhammat Amat; Halmurat Upur
Journal:  BMC Complement Altern Med       Date:  2015-02-12       Impact factor: 3.659

4.  Anti-cancer effect and the underlying mechanisms of gypenosides on human colorectal cancer SW-480 cells.

Authors:  Han Yan; Xiaobing Wang; Junfeng Niu; Yaqin Wang; Pan Wang; Quanhong Liu
Journal:  PLoS One       Date:  2014-04-21       Impact factor: 3.240

5.  Puerarin 6″-O-xyloside possesses significant antitumor activities on colon cancer through inducing apoptosis.

Authors:  Xiao-Lan Zhang; Bin-Bin Wang; Jian-Shu Mo
Journal:  Oncol Lett       Date:  2018-08-24       Impact factor: 2.967

6.  Anti-proliferative effect of Flos Albiziae flavonoids on the human gastric cancer SGC-7901 cell line.

Authors:  Jianmei Yuan; Wanli Li; Yuhui Tian; Xia Wang
Journal:  Exp Ther Med       Date:  2012-10-26       Impact factor: 2.447

7.  Inhibitive effects of mulberry leaf-related extracts on cell adhesion and inflammatory response in human aortic endothelial cells.

Authors:  P-Y Chao; K-H Lin; C-C Chiu; Y-Y Yang; M-Y Huang; C-M Yang
Journal:  Evid Based Complement Alternat Med       Date:  2013-11-28       Impact factor: 2.629

8.  Antioxidant activity of herbaceous plant extracts protect against hydrogen peroxide-induced DNA damage in human lymphocytes.

Authors:  Kuan-Hung Lin; Yan-Yin Yang; Chi-Ming Yang; Meng-Yuan Huang; Hsiao-Feng Lo; Kuang-Chuan Liu; Hwei-Shen Lin; Pi-Yu Chao
Journal:  BMC Res Notes       Date:  2013-11-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.